Background: Oaks are the most common trees in Korean forests, and Mongolian oak, Quercus mongolica, is the dominant species. However, no allergen has been characterized from Mongolian oak. In this study, we tried to characterize a major allergen from Mongolian oak. Methods: A molecule homologous to pathogenesis-related 10 (PR-10)-like protein, Que m 1, was cloned by RT-PCR. Its recombinant protein, along with Que a 1, an allergen from white oak (Q. alba), was produced. The allergenicity and diagnostic value of recombinant Que m 1, Que a 1, and Bet v 1 proteins were compared by ELISA using sera from oak-sensitized subjects. A basophil activation test was also performed using CD63 expression as an activation marker. Results: Que m 1 sequence shares 57.5-96.2% amino acid sequence identity with PR-10-like allergens from various plants. Specific IgE to recombinant Que m 1, Que a 1, and Bet v 1 were detected in 92.0, 74.0, and 38.0% of 50 serum samples from Korean tree pollinosis patients. Recombinant Que m 1 was able to inhibit IgE reactivity to Que a 1 and Bet v 1, indicating its strong cross-reactivity. The activation patterns of basophils from 5 patients were similar in terms of the CD63 expression and protein concentration of challenged Bet v 1 and Que m 1. Conclusions: A major allergen, Que m 1, was cloned, and its recombinant protein was produced from Mongolian oak, a dominant species in Korea. Recombinant Que m 1 is potentially useful for the diagnosis and treatment of tree pollinosis in Korea.

1.
Kim YL, Lee SK, Oh SH, Moon BS, Park HS, Hong CS: A study of allergy skin tests with Korean pollen extracts. Yonsei Med J 1987;28:112-118.
2.
Kim GS, Song HK, Lee CH, Cho HJ, Lee CS: Ecological comparison of Mongolian oak (Quercus mongolica Fisch. Ex Ledeb.) community between Mt. Nam and Mt. Jeombong as a long term ecological research (LTER) site. Korean J Environ Ecol 2011;34:75-85.
3.
Park HJ, Lim HS, Park KH, Lee JH, Park JW, Hong CS: Changes in allergen sensitization over the last 30 years in Korea respiratory allergic patients: a single -center. Allergy Asthma Immunol Res 2014;6:434-443.
4.
Park HJ, Lee JH, Park KH, Kim KR, Han MJ, Choe H, Oh JW, Hong CS: A six-year study on the changes in airborne pollen counts and skin positivity rates in Korea: 2008-2013. Yonsei Med J 2016;57:714-720.
5.
Asam C, Hofer H, Wolf M, Aglas L, Wallner M: Tree pollen allergens - an update from a molecular perspective. Allergy 2015;70:1201-1211.
6.
Fernandes H, Michalska K, Sikorski M, Jaskolski M: Structural and functional aspects of PR-10 proteins. FEMS J 2013;280:1169-1199.
7.
Hauser M, Asam C, Himly M, Palazzo P, Voltolini S, Montanari C, Briza P, Bernardi ML, Mari A, Ferreira F, Wallner M: Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic individuals. Clin Exp Allergy 2011;41:1804-1814.
8.
King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Thomas WR: Allergen nomenclature. WHO/IUIS Allergen Nomenclature Subcommittee. Int Arch Allergy Immunol 1994;105:224-233.
9.
Jeong KY, Son M, Park JH, Park KH, Park HJ, Lee JH, Hong CS, Park JW: Cross-reactivity between oak and birch pollens in Korean tree pollinosis. J Korean Med Sci 2016;31:1202-1207.
10.
Wallner M, Erler A, Hauser M, Klinglmayr E, Gadermaier G, Vogel L, Mari A, Bohle B, Briza P, Ferreira F: Immunologic characterization of isoforms of Car b 1 and Que a 1, the major hornbeam and oak pollen allergens. Allergy 2009;64:452-460.
11.
Santos A, van Ree R: Profilins: minickers of allergy or relevant allergen? Int Arch Allergy Immunol 2011;155:191-204.
12.
San Nicolo M, Braun T, Eder K, Berghaus A, Groger M: Clinical relevance of IgE to profiling and/or polcalcin in pollen-sensitized patients. Int Arch Allergy Immunol 2016;169:101-107.
13.
Ferreira F, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R, Hoffmann-Sommergruber K, Schneiner O, Kraft D, Breitenbach M, Rheinberger HJ, Ebner C: Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.
14.
Larsen JN, Stroman P, Ipsen H: PCR based cloning and sequencing of isogenes encoding the tree pollen major allergen Car b 1 from Carpinus betulus, hornbeam. Mol Immunol 1992;29:703-711.
15.
Moverare R, Everberg H, Carlsson R, Holtz A, Thunberg R, Ollson P, Brostedt P, Hogbom E: Purification and characterization of the major oak pollen allergen Que a 1 for component-resolved diagnosis using ImmunoCAP®. Int Arch Allergy Immunol 2008;146:203-211.
16.
Geroldinger-Simic M, Zelniker T, Aberer W, Ebner C, Egger C, Greiderer A, Prem N, Lidholm J, Ballmer-Weber BK, Vieths S, Bohle B: Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. J Allergy Clin Immunol 2011;127:616-622.
17.
Price A, Ramachadran S, Smith GP, Stevenson ML, Pmeranz MK, Cohen DE: Oral allergy syndrome (pollen-food allergy syndrome). Dermatitis 2015;26:78-88.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.